O Shearman
- Indexed articles, last 90 days
- 17
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Mondaq
- Top 500K sites
- Earliest in this view
- Jul 7, 2026
Latest articles
Northern District Of California Dismisses Putative Securities Class Action Against Value Grocery Retailer Without Prejudice (opens the original)
Read excerpt
On September 16, 2026, Judge Jon S. Tigar of the United States District Court for the Northern District of California dismissed a putative securities class action against a value grocery retailer (the “Company”) and its former CEO and CFO (collectively, “Defendants”). In re Grocery Outlet Holding Corp. Sec. Litig., No. 4:25-cv-957-JST (N.D. Cal. Sept. 16, 2026). Plaintiff alleged violations of Section 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, claiming Defendants conc
District Of Massachusetts Dismisses Putative Class Action Against Gene Therapy Company For Failure To Adequately Allege Misstatements And Scienter (opens the original)
Read excerpt
On September 15, 2026, Judge Brian E. Murphy of the United States District Court for the District of Massachusetts dismissed with prejudice a putative class action asserting claims under the Securities Exchange Act of 1934 against a gene therapy company and certain of its executives. In re Sarepta Therapeutics Sec. Litig., 2026 WL 2720122 (D. Mass. Sept. 15, 2026). Plaintiffs alleged that defendants made material misstatements about the safety of the company’s flagship gene therapy product, the
Southern District Of New York Grants Motion To Dismiss Securities Class Action Against Former Officers Of Business Communications Company (opens the original)
Read excerpt
On September 1, 2026, Judge Paul G. Gardephe of the United States District Court for the Southern District of New York granted a motion to dismiss a putative securities fraud class action against the former CEO and former CFO of a business communications company (the “Company”), alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder. Jiang v. Chirico, et al., No. 23 Civ. 1258 (S.D.N.Y. Sept. 1, 2026). In d
Ninth Circuit Amends Opinion Partially Reviving Putative Class Action Against Manufacturer Of Pop Culture Collectibles And Denies Rehearing Petitions (opens the original)
Read excerpt
On September 2, 2026, the United States Court of Appeals for the Ninth Circuit amended its opinion affirming in part and reversing in part the dismissal of a putative securities fraud class action against a manufacturer of pop culture collectibles (the “Company”), and its former CEO and former CFO, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. Constr. Laborers Pension Trust of Greater St. Louis v. Funko Inc., No. 24-
First Circuit Affirms Dismissal Of Putative Class Action Against Pharmaceutical Company (opens the original)
Read excerpt
On August 19, 2026, the United States Court of Appeals for the First Circuit affirmed the dismissal of a putative class action asserting claims under the Securities Exchange Act of 1934 against a biopharmaceutical company and its CEO. In re Apellis Pharms., Inc. Sec. Litig., —F.4th—, 2026 WL 2425924 (1st Cir. Aug. 19, 2026). Plaintiffs alleged that the company made misrepresentations regarding clinical trials for a drug that was ultimately approved by the Food and Drug Administration (“FDA”). Th
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Mondaq, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.